Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00448279 | THOR Study: A Study of Continued Herceptin (Trastuzumab) in Combination With Second Line Chemotherapy in Patients With HER2 Positive Metastatic Breast Cancer. | completed | Phase 3 | 58 | Hoffmann-La RocheINDUSTRY | 1 | Oct 24, 2014 | clinicaltrials |
| NCT00082095 | To Compare Treatment With Doxorubicin or Capecitabine for Metastatic Breast Cancer in Women 60 Years and Older | terminated | Phase 3 | 62 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 1 |
| Oct 9, 2014 |
| clinicaltrials |
| NCT02249208 | Sentinel Lymph Node Biopsy With Superparamagnetic Iron Oxide for Breast Cancer Patients After Neoadjuvant Treatment.(SENTINAC-01) | unknown | Phase 3 | 150 | Hospital Universitari Vall d'Hebron Research InstituteOTHER | 1 | Sep 30, 2014 | clinicaltrials |
| NCT00320710 | Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast Cancer | completed | Phase 3 | 416 | Novartis PharmaceuticalsINDUSTRY | 1 | Aug 22, 2014 | clinicaltrials |
| NCT00374322 | Tykerb Evaluation After Chemotherapy (TEACH): Lapatinib Versus Placebo In Women With Early-Stage Breast Cancer | completed | Phase 3 | 3,166 | GlaxoSmithKlineINDUSTRY | 33 | Aug 18, 2014 | clinicaltrials |
| NCT00925548 | STRIDE - STimulating Immune Response In aDvanced brEast Cancer(STRIDE) | terminated | Phase 3 | 16 | EMD SeronoINDUSTRY | 12 | Jul 24, 2014 | clinicaltrials |
| NCT00196859 | Study in Elderly Patients With Early Breast Cancer (ICE) | completed | Phase 3 | 1,500 | GBG Forschungs GmbHOTHER | 1 | Jul 17, 2014 | clinicaltrials |
| NCT00196872 | A Study to Compare ETC vs. EC-TX and Ibandronate vs. Observation in Patients With Node-positive Primary Breast Cancer (GAIN) | completed | Phase 3 | 3,000 | GBG Forschungs GmbHOTHER | 1 | Jul 17, 2014 | clinicaltrials |
| NCT02181101 | Simultaneous Study of Gemcitabine-Docetaxel Combination Adjuvant Treatment, as Well as Extended Bisphosphonate and Surveillance-Trial | completed | Phase 3 | 3,754 | Ludwig-Maximilians - University of MunichOTHER | 1 | Jul 3, 2014 | clinicaltrials |
| NCT01185132 | Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy(2009-APBI) | recruiting | Phase 3 | 660 | Rocky Mountain Cancer CentersOTHER | 1 | Jun 26, 2014 | clinicaltrials |
| NCT01402193 | Study of Arimidex and Radiotherapy Sequencing | unknown | Phase 3 | 220 | Fudan UniversityOTHER | 1 | Jun 25, 2014 | clinicaltrials |
| NCT00109239 | A Study of rhuMAb VEGF (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Treated Breast Cancer | completed | Phase 3 | — | Genentech, Inc.INDUSTRY | 0 | Jun 18, 2014 | clinicaltrials |
| NCT00547989 | Paravertebral Block, an Adjunct to General Anaesthesia for Breast Surgery? | completed | Phase 3 | 46 | Maastricht University Medical CenterOTHER | 1 | Jun 11, 2014 | clinicaltrials |
| NCT02132390 | Adjuvant Toremifene With or Without Goserrelin in Premenopausal Women With Stage I-IIIA, Hormonal Receptor Positive Breast Cancer Accompanied With or Without Chemotherapy Induced Amenorrhoea | unknown | Phase 3 | 300 | Peking Union Medical College HospitalOTHER | 1 | Jun 4, 2014 | clinicaltrials |
| NCT01142479 | Compound Herbal Formula (TPE-1) for Leukopenia and Cancer-related Fatigue in Breast Cancer Patients With Radiotherapy | completed | Phase 2 / Phase 3 | 60 | Taipei City HospitalOTHER_GOV | 1 | May 29, 2014 | clinicaltrials |
| NCT02141139 | Perioperative Inflammation and Breast Cancer Outcome | unknown | Phase 3 | 1,568 | Samsung Medical CenterOTHER | 1 | May 19, 2014 | clinicaltrials |
| NCT01985724 | Sequential Administration of FE75C and Docetaxel Versus Docetaxel/Cyclophosphamide in HER-2 Negative, Node Positive Breast Cancer | completed | Phase 3 | 650 | Hellenic Oncology Research GroupOTHER | 1 | May 14, 2014 | clinicaltrials |
| NCT00038467 | Randomized Trial Of Exemestane Versus Continued Tamoxifen In Postmenopausal Women With Early Breast Cancer(IES) | completed | Phase 3 | 4,740 | PfizerINDUSTRY | 37 | May 7, 2014 | clinicaltrials |
| NCT01355523 | The Effect of Melatonin on Depression, Anxiety, Cognitive Function and Sleep Disturbances in Breast Cancer Patients(MELODY) | terminated | Phase 2 / Phase 3 | 54 | Melissa Voigt HansenOTHER | 1 | May 6, 2014 | clinicaltrials |
| NCT01459003 | Evaluation of Beauty Care Before Chemotherapy in Women With Breast Cancer(BEAUTY) | completed | Phase 3 | 400 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | May 6, 2014 | clinicaltrials |
| NCT00712985 | Single Dosing of Zoledronic Acid in Cancer Therapy Induced Bone Loss (CTIBL)(CTIBL) | completed | Phase 3 | 18 | Milton S. Hershey Medical CenterOTHER | 1 | Apr 24, 2014 | clinicaltrials |
| NCT00091442 | A Study of Docetaxel Monotherapy or DOXIL and Docetaxel in Patients With Advanced Breast Cancer | completed | Phase 3 | 751 | Johnson & Johnson Pharmaceutical Research & Development, L.L.C.INDUSTRY | 18 | Apr 21, 2014 | clinicaltrials |
| NCT01559194 | Low Fat Versus Protein Sparing Diet for Weight Loss & Impact on Biomarkers Associated With Breast Cancer Risk(LEAF) | completed | Phase 3 | 82 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Apr 14, 2014 | clinicaltrials |
| NCT02109068 | Lifestyle, Exercise and Nutrition Study 1(LEAN) | completed | Phase 3 | 100 | Yale UniversityOTHER | 1 | Apr 9, 2014 | clinicaltrials |
| NCT00010322 | Toremifene With or Without Atamestane in Treating Postmenopausal Women With Metastatic Breast Cancer | terminated | Phase 3 | — | Intarcia TherapeuticsINDUSTRY | 1 | Mar 26, 2014 | clinicaltrials |
| NCT00096967 | A Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study | completed | Phase 3 | 100 | Genentech, Inc.INDUSTRY | 0 | Mar 26, 2014 | clinicaltrials |
| NCT00175344 | Does Scar Massage Improve Postoperative Pain and Function in Women With Breast Cancer? | completed | Phase 3 | 96 | University of British ColumbiaOTHER | 1 | Feb 19, 2014 | clinicaltrials |
| NCT01392586 | Systemic Therapy With or Without Upfront Surgery in Metastatic Breast Cancer(SUBMIT) | terminated | Phase 3 | 10 | Jeroen Bosch ZiekenhuisOTHER | 1 | Feb 4, 2014 | clinicaltrials |
| NCT02035631 | Prevention of Breast Cancer Recurrence Through Weight Control, Diet, and Physical Activity Intervention(PREDICOP) | unknown | Phase 3 | 2,000 | Institut Català d'OncologiaOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT00049452 | Zoledronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy After Surgery For Early Stage Breast Cancer | completed | Phase 3 | 120 | Herbert Irving Comprehensive Cancer CenterOTHER | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00312208 | Docetaxel in Breast Cancer | completed | Phase 3 | 3,299 | SanofiINDUSTRY | 37 | Dec 30, 2013 | clinicaltrials |
| NCT00003418 | Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast Cancer | unknown | Phase 3 | 4,400 | International Collaborative Cancer GroupOTHER | 3 | Dec 19, 2013 | clinicaltrials |
| NCT00003577 | Combination Chemotherapy With or Without Epirubicin in Treating Women With Stage I or Stage II Breast Cancer | completed | Phase 3 | 2,000 | University Hospital BirminghamOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00003678 | Tamoxifen in Treating Women With Breast Cancer | unknown | Phase 3 | 20,000 | University Hospital BirminghamOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00003893 | Adjuvant Chemotherapy Plus Radiation Therapy in Treating Women With Early-Stage Breast Cancer | completed | Phase 3 | 2,250 | University Hospital BirminghamOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00005587 | Radiation Therapy After Surgery in Treating Women With Early Stage Breast Cancer | completed | Phase 3 | — | Medical Research CouncilOTHER_GOV | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00005588 | Radiation Therapy After Surgery in Treating Women With Early Stage Breast Cancer | completed | Phase 3 | — | Medical Research CouncilOTHER_GOV | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00513916 | Effect of Dietary Soy on Estrogens in Breast Fluid, Blood, and Urine Samples From Healthy Women | completed | Phase 3 | 100 | University of Hawaii Cancer Research CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00005581 | Combination Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer | unknown | Phase 3 | 1,000 | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, ItalyOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00010140 | Epirubicin and Tamoxifen With or Without Docetaxel in Treating Postmenopausal Women With Breast Cancer | unknown | Phase 3 | — | International Collaborative Cancer GroupOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00859989 | A Weight-Loss Program in Helping Obese Black Women Lose Weight | unknown | Phase 3 | 200 | University of Illinois at ChicagoOTHER | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00262067 | A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1) | unknown | Phase 3 | 1,237 | Genentech, Inc.INDUSTRY | 22 | Dec 13, 2013 | clinicaltrials |
| NCT00002953 | Epirubicin and Cyclophosphamide Compared With Epirubicin and Paclitaxel in Treating Women With Metastatic Breast Cancer | completed | Phase 3 | 704 | Medical Research CouncilOTHER_GOV | 2 | Dec 4, 2013 | clinicaltrials |
| NCT00301080 | D-cycloserine in the Management of Chemotherapy-Induced Peripheral Neuropathic Pain | terminated | Phase 3 | 7 | Northwestern UniversityOTHER | 1 | Dec 2, 2013 | clinicaltrials |
| NCT00301886 | S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone | withdrawn | Phase 3 | 0 | SWOG Cancer Research NetworkNETWORK | 0 | Nov 13, 2013 | clinicaltrials |
| NCT00002579 | Tamoxifen Following Combination Chemotherapy in Treating Women With Operable Invasive Breast Cancer | completed | Phase 3 | 2,000 | Scottish Cancer Therapy NetworkOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00002580 | Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer | completed | Phase 3 | 1,000 | Scottish Cancer Therapy NetworkOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00002581 | Tamoxifen With or Without Combination Chemotherapy in Treating Postmenopausal Women With Operable Invasive Breast Cancer | completed | Phase 3 | 1,000 | Scottish Cancer Therapy NetworkOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00002755 | Standard Chemotherapy Compared With High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer | completed | Phase 3 | 600 | Scottish Cancer Therapy NetworkOTHER | 2 | Nov 6, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Oct 24, 2014source: clinicaltrials